These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37235264)

  • 1. Per- and Polyfluoroalkyl Substances (PFAS) Mixture during Pregnancy and Postpartum Weight Retention in the New Hampshire Birth Cohort Study (NHBCS).
    Wang Y; Howe C; Gallagher LG; Botelho JC; Calafat AM; Karagas MR; Romano ME
    Toxics; 2023 May; 11(5):. PubMed ID: 37235264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Per- and polyfluoroalkyl substances, gestational weight gain, postpartum weight retention and body composition in the UPSIDE cohort.
    Kinkade CW; Rivera-Núñez Z; Thurston SW; Kannan K; Miller RK; Brunner J; Wong E; Groth S; O'Connor TG; Barrett ES
    Environ Health; 2023 Sep; 22(1):61. PubMed ID: 37658449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach.
    Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK
    Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Per- and polyfluoroalkyl substance mixtures and gestational weight gain among mothers in the Health Outcomes and Measures of the Environment study.
    Romano ME; Gallagher LG; Eliot MN; Calafat AM; Chen A; Yolton K; Lanphear B; Braun JM
    Int J Hyg Environ Health; 2021 Jan; 231():113660. PubMed ID: 33181449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Concentrations of Per- and Polyfluoroalkyl Substances and Body Composition From Mid-Childhood to Early Adolescence.
    Janis JA; Rifas-Shiman SL; Seshasayee SM; Sagiv S; Calafat AM; Gold DR; Coull BA; Rosen CJ; Oken E; Fleisch AF
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3760-e3770. PubMed ID: 33740056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfluoroalkyl Substances during Pregnancy and Offspring Weight and Adiposity at Birth: Examining Mediation by Maternal Fasting Glucose in the Healthy Start Study.
    Starling AP; Adgate JL; Hamman RF; Kechris K; Calafat AM; Ye X; Dabelea D
    Environ Health Perspect; 2017 Jun; 125(6):067016. PubMed ID: 28669937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gestational per- and polyfluoroalkyl substances exposure and infant body mass index trajectory in the New Hampshire Birth Cohort Study.
    Romano ME; Heggeseth BC; Gallagher LG; Botelho JC; Calafat AM; Gilbert-Diamond D; Karagas MR
    Environ Res; 2022 Dec; 215(Pt 3):114418. PubMed ID: 36162478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFAS) and child executive function and behavioral problems.
    Harris MH; Oken E; Rifas-Shiman SL; Calafat AM; Bellinger DC; Webster TF; White RF; Sagiv SK
    Environ Res; 2021 Nov; 202():111621. PubMed ID: 34237332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-pregnancy plasma per- and polyfluoroalkyl substance (PFAS) concentrations and hypertensive disorders of pregnancy in the Project Viva cohort.
    Preston EV; Hivert MF; Fleisch AF; Calafat AM; Sagiv SK; Perng W; Rifas-Shiman SL; Chavarro JE; Oken E; Zota AR; James-Todd T
    Environ Int; 2022 Jul; 165():107335. PubMed ID: 35696844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and neurobehavior in US children through 8 years of age: The HOME study.
    Vuong AM; Webster GM; Yolton K; Calafat AM; Muckle G; Lanphear BP; Chen A
    Environ Res; 2021 Apr; 195():110825. PubMed ID: 33545124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal exposure to per- and polyfluoroalkyl substances and infant growth and adiposity: the Healthy Start Study.
    Starling AP; Adgate JL; Hamman RF; Kechris K; Calafat AM; Dabelea D
    Environ Int; 2019 Oct; 131():104983. PubMed ID: 31284113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Changes in Maternal Serum Concentrations of Per- and Polyfluoroalkyl Substances from Pregnancy to Two Years Postpartum.
    Oh J; Bennett DH; Tancredi DJ; Calafat AM; Schmidt RJ; Hertz-Picciotto I; Shin HM
    Environ Sci Technol; 2022 Aug; 56(16):11449-11459. PubMed ID: 35904360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal Plasma per- and Polyfluoroalkyl Substance Concentrations in Early Pregnancy and Maternal and Neonatal Thyroid Function in a Prospective Birth Cohort: Project Viva (USA).
    Preston EV; Webster TF; Oken E; Claus Henn B; McClean MD; Rifas-Shiman SL; Pearce EN; Braverman LE; Calafat AM; Ye X; Sagiv SK
    Environ Health Perspect; 2018 Feb; 126(2):027013. PubMed ID: 29488882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal and Childhood Per- and Polyfluoroalkyl Substance (PFAS) Exposures and Blood Pressure Trajectories From Birth to Late Adolescence in a Prospective US Prebirth Cohort.
    Zhang M; Aris IM; Lin PD; Rifas-Shiman SL; Brady TM; James-Todd T; Oken E; Hivert MF
    J Am Heart Assoc; 2023 Sep; 12(17):e030760. PubMed ID: 37642023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gestational and childhood exposure to per- and polyfluoroalkyl substances and cardiometabolic risk at age 12 years.
    Li N; Liu Y; Papandonatos GD; Calafat AM; Eaton CB; Kelsey KT; Cecil KM; Kalkwarf HJ; Yolton K; Lanphear BP; Chen A; Braun JM
    Environ Int; 2021 Feb; 147():106344. PubMed ID: 33418195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of Per- and Polyfluoroalkyl Substances in Paired Maternal Plasma and Human Milk in the New Hampshire Birth Cohort.
    Criswell RL; Wang Y; Christensen B; Botelho JC; Calafat AM; Peterson LA; Huset CA; Karagas MR; Romano ME
    Environ Sci Technol; 2023 Jan; 57(1):463-472. PubMed ID: 36574487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Maternal Serum Perfluoroalkyl Substances Concentrations with Early Adolescent Bone Mineral Content and Density: The Health Outcomes and Measures of the Environment (HOME) Study.
    Buckley JP; Kuiper JR; Lanphear BP; Calafat AM; Cecil KM; Chen A; Xu Y; Yolton K; Kalkwarf HJ; Braun JM
    Environ Health Perspect; 2021 Sep; 129(9):97011. PubMed ID: 34585601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.